We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Molecular Diagnostics

Image Credit: Shutterstock

Rare Genetic Variant Linked to Dramatically Higher Lung Cancer Risk

New data link rare inherited EGFR variant to 25-fold higher lung cancer risk, informing genetic screening. More...
21 Sep 2026
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

A new CRISPR-based test identifies NTM species from respiratory samples within hours with 97.3% accuracy. More...
17 Sep 2026
Image: Now FDA-cleared, Metrix brings lab-quality molecular testing to urgent care and other decentralized settings, without the cost, footprint, or complexity of traditional systems (Photo courtesy of Aptitude Medical Systems)

FDA Clears Compact Molecular COVID Test for Decentralized Care Settings

A new FDA-cleared hand-held molecular test delivers faster, more sensitive COVID results for CLIA-waived use. More...
17 Sep 2026
Image Credit: Adobe Stock

Blood-Based DNA Analysis Method Detects Early-Stage Solid Cancers

A new liquid biopsy detects stage I/II solid cancers from plasma ctDNA with 95% early-stage sensitivity. More...
15 Sep 2026
Image: Researchers found that combining two Alzheimer’s tests—a p-tau217 blood test and APOE genotyping—can predict symptom onset in people who are not yet experiencing symptoms (Image Credit: Adobe Stock)

Combined Blood and Genetic Tests Estimate Timing of Alzheimer’s Symptom Onset

A combined blood-based Alzheimer’s marker and genetic risk test estimates time to symptom onset within 3–6 years in asymptomatic adults. More...
14 Sep 2026
Image: Blood protein levels can reveal whether genetic variants have biological effects, potentially offering a more scalable, noninvasive way to obtain additional patient information (Image Credit: 123RF)

Blood Protein Analysis Helps Interpret Uncertain Rare Disease Variants

A new blood proteomics–genomics approach improves interpretation of uncertain variants and supports rare disease diagnosis. More...
12 Sep 2026
Image: DecisionDx-SCC evaluates expression of 40 tumor genes and integrates those data with five clinicopathologic risk factors for high-risk cutaneous squamous cell carcinoma (Image Credit: 123RF)

40-Gene Test Validated for High-Risk Squamous Cell Carcinoma

An integrated 40‑gene expression test improves prognostic accuracy and guides adjuvant radiation in high‑risk cSCC. More...
10 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
All-in-One Molecular System
AIO M160


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.